Franklin Resources
KRYS icon

Franklin Resources’s Krystal Biotech KRYS Stock Holding History

Franklin Resources’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.3M Buy
261,917
+82,652
+46% +$24.7M 0.02% 464
2026
Q1 		$46.3M Buy
179,265
+53,590
+43% +$14.3M 0.01% 675
2025
Q4 		$31M Buy
125,675
+105,825
+533% +$22.3M 0.01% 809
2025
Q3 		$3.5M Buy
19,850
+1,425
+8% +$213K ﹤0.01% 1575
2025
Q2 		$2.53M Sell
18,425
-588
-3% -$86.4K ﹤0.01% 1635
2025
Q1 		$3.43M Sell
19,013
-165,014
-90% -$27.8M ﹤0.01% 1491
2024
Q4 		$28.8M Sell
184,027
-59,733
-25% -$10.6M 0.01% 796
2024
Q3 		$43.8M Buy
243,760
+62,178
+34% +$12M 0.01% 650
2024
Q2 		$33.3M Buy
181,582
+50,117
+38% +$8.41M 0.01% 679
2024
Q1 		$23.4M Buy
131,465
+104,919
+395% +$14.6M 0.01% 816
2023
Q4 		$3.29M Buy
26,546
+68
+0.3% +$7.54K ﹤0.01% 1234
2023
Q3 		$3.07M Buy
26,478
+11,238
+74% +$1.37M ﹤0.01% 1234
2023
Q2 		$1.79M Buy
15,240
+10,608
+229% +$1.08M ﹤0.01% 1450
2023
Q1 		$371K Hold
4,632
– – ﹤0.01% 1790
2022
Q4 		$367K Buy
4,632
+25
+0.5% +$1.86K ﹤0.01% 1791
2022
Q3 		$321K Buy
4,607
+1,141
+33% +$82.4K ﹤0.01% 1823
2022
Q2 		$228K Sell
3,466
-271
-7% -$16.9K ﹤0.01% 1979
2022
Q1 		$249K Buy
+3,737
New +$233K ﹤0.01% 2088
2021
Q4 		– Sell
-140,004
Closed -$7.31M – 2517
2021
Q3 		$7.31M Hold
140,004
– – ﹤0.01% 1125
2021
Q2 		$9.52M Buy
140,004
+15,000
+12% +$1.05M ﹤0.01% 1015
2021
Q1 		$9.63M Buy
+125,004
New +$9.09M ﹤0.01% 982

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources's KRYS Position: Q2 2026 in Review

Franklin Resources increased its Krystal Biotech (KRYS) stake by 46% in Q2 2026, buying an estimated $24.7M and bringing the position to 261,917 shares worth $97.3M. The position accounts for 0.02% of the portfolio, ranked #464.

Franklin Resources first reported a position in KRYS in Q1 2021 and has held it in 21 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Franklin Resources held 261,917 shares of Krystal Biotech worth $97.3M as of Q2 2026.
  • Franklin Resources bought 82,652 Krystal Biotech shares in Q2 2026, an estimated $24.7M.
  • Krystal Biotech made up 0.02% of Franklin Resources's portfolio in Q2 2026, its #464 holding.
  • Franklin Resources first reported a position in Krystal Biotech in Q1 2021 and has held it in 21 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.